PrimaCure is a Korea-based regenerative science company focused on developing clinically-driven solutions in skin, hair care and beyond. The company specializes in advanced extracellular vesicle and exosome technologies designed to restore biological function at the cellular level.
Founded in 2021, PrimaCure operates at the intersection of biotechnology and aesthetic medicine, translating complex cellular research into practical, protocol-based treatments for clinicians. Its flagship E-50 platform is built around standardized, high-purity exosome formulations derived from salmon supported by structured clinical application methods for both skin and hair indications.
PrimaCure’s approach emphasizes clinical validation, mechanism-driven protocols, and physician education, rather than trend-based aesthetic solutions.
Today, PrimaCure is expanding internationally across key markets in Europe, Asia, Americas, and the Middle East, collaborating with medical professionals and institutions to advance the adoption of regenerative therapies in everyday practice.